Back
Royal Bank of Canada Vs. CRISPR Therapeutics AG Industry Stock Comparison
Buy
68
RY
Royal Bank of Canada
Last Price:
$117.76
Seasonality Move:
2.6%
Sell
34
CRSP
CRISPR Therapeutics AG
Last Price:
$38.28
Seasonality Move:
20.1%
Buy
68
Royal Bank of Canada (RY)
is a Buy
Is Royal Bank of Canada a Buy, Sell or Hold?
-
The current Royal Bank of Canada [RY] share price is $117.76. The Score for RY is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
RY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $38.27. The Score for CRSP is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RY Stock Price Chart
What is Royal Bank of Canada's stock price today?
-
The Royal Bank of Canada share price today is $117.76Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RY is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $38.27The current trend is moderately bullish and CRSP is experiencing slight selling pressure.
RY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.83 | Buy |
| Relative Strength Index (14 RSI): | 57.56 | Buy |
| Chaikin Money Flow: | 457135 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (111.77 - 117.01) | Buy |
| Bollinger Bands (100): | (114.09 - 123.03) | Sell |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.07 | Buy |
| Relative Strength Index (14 RSI): | 50.42 | Buy |
| Chaikin Money Flow: | -525417 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.9 - 40.02) | Buy |
| Bollinger Bands (100): | (37.22 - 46.82) | Sell |
RY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 116.68 | Buy |
| 20-day SMA: | 114.13 | Buy |
| 50-day SMA: | 115.12 | Buy |
| 200-day SMA: | 118.45 | Sell |
| 8-day EMA: | 116.59 | Buy |
| 20-day EMA: | 115.23 | Buy |
| 50-day EMA: | 115.66 | Buy |
| 200-day EMA: | 115.58 | Buy |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.43 | Sell |
| 20-day SMA: | 36.1 | Buy |
| 50-day SMA: | 40.71 | Sell |
| 200-day SMA: | 45.82 | Sell |
| 8-day EMA: | 38.12 | Buy |
| 20-day EMA: | 34.63 | Buy |
| 50-day EMA: | 24.01 | Buy |
| 200-day EMA: | 8.5 | Buy |
Royal Bank of Canada Earnings Growth & RY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.19 per share, an increase this year of $1.10 per share, and an increase next year of $0.69 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.04 per share, an increase this year of $0.16 per share, and an increase next year of $0.94 per share.
Royal Bank of Canada Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||